FEB 22, 2022 8:00 AM PST

Beta-blockers as a Potential Treatment for COVID-19

WRITTEN BY: Savannah Logan

Beta-blockers are relatively common medications used to treat high blood pressure, abnormal heart rhythms, and a range of other conditions. They work by blocking epinephrine (a.k.a. adrenaline), which causes lower heart rates and less forceful heartbeats. By blocking those receptors in the body, beta-blockers can impact the body’s “fight-or-flight” response.

Recently, researchers have been looking into whether beta-blockers may be useful in treating COVID-19. COVID-19 illness can be divided into three stages: stage I, the early viral response characterized by flu-like symptoms; stage II, the pulmonary phase with possible pneumonia and respiratory symptoms; and stage III, a “hyperinflammatory” phase in which organ failure may occur. Patients in stage III are often affected by acute respiratory distress syndrome (ARDS). A study recently published in the Journal of the American College of Cardiology suggests that metoprolol, a common beta-blocker, may be useful in treating COVID-induced ARDS.

The researchers who conducted the study randomized 20 COVID-19 patients with ARDS to be treated with metopropol or to be in a control group that received no additional treatment. They saw that the patients treated with metopropol had reduced lung inflammation and improved oxygenation with no side effects. While this was a small pilot study, its results suggest that metopropol may be a simple and inexpensive way to treat ARDS in COVID patients.

Beta-blockers like metopropol may be useful in treating ARDS because they help terminate exacerbated inflammation, which plays a major role in COVID-induced ARDS. This exacerbated inflammation is caused in part by an excessive immune response and the overactivation of neutrophils (a type of white blood cell and essential component of the immune system). Metopropol “stuns” neutrophils and can reduce neutrophil counts in the lungs, leading to positive outcomes for COVID patients.

Sources: Mayo Clinic, News-Medical, Journal of the American College of Cardiology, Medical News Today

About the Author
PhD in Biophysics
Savannah (she/her) is a scientific writer specializing in cardiology at Labroots. Her background is in medical writing with significant experience in obesity, oncology, and infectious diseases. She has conducted research in microbial biophysics, optics, and education. She received her Ph.D. from the University of Oregon.
You May Also Like
FEB 17, 2022
Cardiology
10 Minutes of Exercise Per Day May Increase Your Lifespan
FEB 17, 2022
10 Minutes of Exercise Per Day May Increase Your Lifespan
A quick walk around the block every day may help you live longer.
MAR 17, 2022
Cardiology
Coffee May Lower Risk of Heart Failure
MAR 17, 2022
Coffee May Lower Risk of Heart Failure
A new study has linked caffeinated coffee to a lower risk of heart failure.
MAY 19, 2022
Cardiology
Death from Heart Attacks More Common in US than Other High-Income Countries
MAY 19, 2022
Death from Heart Attacks More Common in US than Other High-Income Countries
The US has a high rate of heart attack mortality compared to other high-income countries.
JUL 16, 2022
Drug Discovery & Development
Whole Blood Exchange May Reduce Amyloid Plaques in Alzheimer's
JUL 16, 2022
Whole Blood Exchange May Reduce Amyloid Plaques in Alzheimer's
Whole blood exchange reduces the formation of amyloid beta plaques in mouse models of Alzheimer's disease. The corre ...
AUG 16, 2022
Cardiology
Using Table Salt Is Linked to Premature Death
AUG 16, 2022
Using Table Salt Is Linked to Premature Death
If you frequently add salt to your food at the table, you may be at a higher risk of dying early.
AUG 16, 2022
Cardiology
Coffee May Reduce the Risk of Atrial Fibrillation
AUG 16, 2022
Coffee May Reduce the Risk of Atrial Fibrillation
Coffee, also known as java, joe, mud, the elixir of life, and so many other terms, is one of the most popular drinks wor ...
Loading Comments...